Ethicon v. Intuitive Surgical: 7-Patent Robotic Surgery Dispute Dismissed With Prejudice
Ethicon LLC, Ethicon Endo-Surgery, and Ethicon US sued Intuitive Surgical over seven patents covering robotic surgical instruments used in the Da Vinci Surgical System and EndoWrist product line. After 2,532 days of litigation in the Delaware District Court, all claims were dismissed with prejudice by joint stipulation, with each party bearing its own costs.
Seven-Year Robotic Surgery Patent War Ends by Mutual Stipulation
Ethicon LLC, Ethicon Endo-Surgery, Inc., and Ethicon US, LLC — all subsidiaries of Johnson & Johnson — filed suit on June 30, 2017 in the U.S. District Court for the District of Delaware against Intuitive Surgical, Inc. and its affiliated entities. The complaint alleged infringement of seven U.S. patents covering robotic surgical instrument technology, including endoscopic staplers and articulating end-effector mechanisms embodied in Intuitive’s Da Vinci Surgical Systems and EndoWrist Instruments.
The case concluded on June 5, 2024, when the parties filed a joint stipulation of dismissal under Federal Rule of Civil Procedure 41(a)(1)(A)(ii), dismissing all claims with prejudice. A dismissal with prejudice is a final adjudication on the merits as a matter of law — Ethicon may not refile the same claims against Intuitive Surgical. Notably, each party agreed to bear its own attorneys’ fees and costs, which is consistent with a negotiated resolution rather than a court-ordered outcome.
The case’s 2,532-day duration — nearly seven years — suggests significant procedural complexity, likely including claim construction, inter partes review proceedings at the USPTO, and substantial discovery. The mutual cost-bearing provision and the absence of any damages award on the public record are consistent with a confidential settlement, though the terms of any underlying agreement remain undisclosed. What drove the ultimate resolution — whether commercial, licensing-related, or strategic — cannot be determined from the public docket alone.
Filing to Dismissed with Prejudice in 2532 days
Nearly 7 years of litigation — well above the median patent case duration in Delaware.
Dismissed with prejudice by stipulation: what this means for both parties
Rule 41 stipulated dismissal with prejudice explained
A dismissal under Fed. R. Civ. P. 41(a)(1)(A)(ii) requires agreement of all parties who have appeared. ‘With prejudice’ elevates the dismissal to a final judgment on the merits — Ethicon is permanently barred from reasserting these seven patents against Intuitive Surgical on the same claims. The court need not issue a merits ruling; the parties’ agreement itself carries preclusive effect.
Permanent bar on re-filingEthicon forfeits the right to re-litigate these claims
By agreeing to dismissal with prejudice, Ethicon permanently surrendered its ability to pursue infringement claims on these seven patents against Intuitive Surgical on the same accused products. However, the patents themselves remain in force until their statutory expiry and could potentially be asserted against different defendants or on different products, subject to estoppel analysis. Any licensing consideration exchanged is not reflected in the public record.
Claims extinguished, patents intactIntuitive Surgical achieves permanent closure on seven patent claims
For Intuitive Surgical, the with-prejudice dismissal provides strong legal certainty: Ethicon cannot reopen these specific infringement claims. The mutual cost-bearing provision also confirms Intuitive avoided a fee-shifting order. Given the Da Vinci platform’s commercial centrality to Intuitive’s business, resolving — or quietly settling — this dispute removes a material litigation risk that had been pending since mid-2017.
Litigation risk resolvedRobotic surgery IP landscape: what the resolution signals
The protracted duration and quiet resolution of this dispute is consistent with a broader pattern of J&J/Ethicon and Intuitive Surgical managing their competitive relationship through IP leverage and negotiation rather than courtroom verdicts. For competitors and new entrants in the robotic surgical instrument space, the survival of these seven patents and the lack of any invalidity ruling means the patents remain a live risk factor in freedom-to-operate analysis for EndoWrist-type articulating instruments.
Patents remain enforceableFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Ethicon, LLC | Company | Surgical device subsidiaries of Johnson & Johnson — holders of US9113874B2 and 6 related patentsSearch in Eureka ↗ |
| Co-Plaintiff | Ethicon US, LLC | Company | Search in Eureka ↗ |
| Co-Plaintiff | Ethicon Endo-Surgery, Inc | Company | Search in Eureka ↗ |
| Defendant | Intuitive Surgical, Inc. | Company | Intuitive Surgical, Inc. — developer and manufacturer of the Da Vinci robotic surgical platformSearch in Eureka ↗ |
| Co-Defendant | Intuitive Surgical Operations, Inc. | Company | Search in Eureka ↗ |
| Co-Defendant | Intuitive Surgical Holdings, LLC | Company | Search in Eureka ↗ |
| Plaintiff counsel | Anish R. Desai | Attorney | Counsel for Ethicon, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Brian P. Egan | Attorney | Counsel for Ethicon, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Christopher M. Pepe | Attorney | Counsel for Ethicon, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Christopher T. Marando | Attorney | Counsel for Ethicon, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Daniel Musher | Attorney | Counsel for Ethicon, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Elizabeth S. Weiswasser | Attorney | Counsel for Ethicon, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Jack B. Blumenfeld | Attorney | Counsel for Ethicon, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Matthew D. Sieger | Attorney | Counsel for Ethicon, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Morris, Nichols, Arsht & Tunnell LLP | Law Firm | Representing Ethicon, LLCSearch in Eureka ↗ |
| Defendant counsel | Andrew Russell | Attorney | Counsel for Intuitive Surgical, Inc.Search in Eureka ↗ |
| Defendant counsel | Brian L. Ferrall | Attorney | Counsel for Intuitive Surgical, Inc.Search in Eureka ↗ |
| Defendant counsel | David M. Fry | Attorney | Counsel for Intuitive Surgical, Inc.Search in Eureka ↗ |
| Defendant counsel | Divya Musinipally | Attorney | Counsel for Intuitive Surgical, Inc.Search in Eureka ↗ |
| Defendant counsel | Eduardo E. Santacana | Attorney | Counsel for Intuitive Surgical, Inc.Search in Eureka ↗ |
| Defendant counsel | John W. Shaw | Attorney | Counsel for Intuitive Surgical, Inc.Search in Eureka ↗ |
| Defendant counsel | Leo L. Lam | Attorney | Counsel for Intuitive Surgical, Inc.Search in Eureka ↗ |
| Defendant counsel | Nathan Roger Hoeschen | Attorney | Counsel for Intuitive Surgical, Inc.Search in Eureka ↗ |
| Defendant counsel | R. Adam Lauridsen | Attorney | Counsel for Intuitive Surgical, Inc.Search in Eureka ↗ |
| Defendant counsel | Robert A. Van Nest | Attorney | Counsel for Intuitive Surgical, Inc.Search in Eureka ↗ |
| Defendant counsel | William S. Hicks | Attorney | Counsel for Intuitive Surgical, Inc.Search in Eureka ↗ |
| Defendant law firm | JPMorgan Chase & Co. | Law Firm | Representing Intuitive Surgical, Inc.Search in Eureka ↗ |
| Defendant law firm | Shaw Keller LLP | Law Firm | Representing Intuitive Surgical, Inc.Search in Eureka ↗ |
| Presiding judge | Judge Gregory B. Williams | Judge | Delaware District CourtSearch in Eureka ↗ |
Official order — verbatim text
The stipulation is textually precise: it invokes Rule 41(a)(1)(A)(ii), names all six party entities explicitly, and specifies dismissal ‘with prejudice’ alongside a mutual cost-bearing provision. The with-prejudice designation is legally significant — it constitutes a final judgment on the merits, triggering claim preclusion. The explicit cost-neutrality clause suggests neither party sought or obtained a finding of exceptional case status under 35 U.S.C. § 285. The absence of any damages figure or injunctive relief in the public record is consistent with terms, if any, remaining confidential.
US9113874B2 and six further Ethicon surgical instrument patents
The seven patents at issue — US9113874B2, US9084601B2, US8991677B2, US8998058B2, US8479969B2, US8616431B2, and US9585658B2 — collectively cover a range of robotic and endoscopic surgical instrument technologies, including articulating end-effectors, stapling and cutting mechanisms, and instrument drive systems. The application dates span from 2012 to 2016, placing them squarely in the generation of IP that underpins current minimally invasive robotic surgery platforms. These patents were asserted against Intuitive Surgical’s Da Vinci Surgical System and EndoWrist Instruments.
Strategically, this portfolio reflects Ethicon’s effort to establish IP boundaries around the instrument-side of robotic surgery — the EndoWrist-compatible tools rather than the robotic console itself. As the robotic surgery market expands beyond Intuitive’s incumbency, with competitors including Medtronic Hugo, CMR Surgical Versius, and Johnson & Johnson’s own Ottava platform entering the field, the enforceability and claim scope of this portfolio carries significant implications. The absence of any invalidity finding means each patent remains a competitive instrument in Ethicon’s arsenal.
Should you run an FTO against Ethicon’s robotic surgical instrument patents?
Any company designing, manufacturing, or commercialising robotic surgical instruments with articulating end-effectors, stapling mechanisms, or motorised drive systems — particularly those intended to interface with or compete against Da Vinci-compatible platforms — should treat this patent family as a priority FTO target. The seven patents survived nearly seven years of litigation without any invalidity or unenforceability ruling, leaving their claims intact. New entrants seeking FDA 510(k) clearance for EndoWrist-type instruments face particular exposure.
PatSnap Eureka’s FTO Search Agent can map your product’s technical features against the claim language of all seven asserted patents, flag any co-pending continuations or divisionals, and surface IPR or ex parte reexamination history that may have narrowed or confirmed claim scope. Eureka’s citation and family tree analysis also identifies whether Ethicon has filed related applications that extend beyond the patents litigated in this case — critical intelligence for product teams finalising instrument design specifications.
Run a freedom-to-operate analysis on US9113874B2 to assess your product’s exposure
Run FTO in Eureka →Similar robotic surgical instrument patent cases in Delaware and beyond
Explore related patent infringement actions involving robotic surgical instruments, EndoWrist technology, and minimally invasive device patents litigated in Delaware District Court.
What this case signals for the robotic surgical instruments IP landscape
A seven-year dispute over Da Vinci and EndoWrist patents ends quietly — but the legal and competitive signals are significant for the sector.
No invalidity ruling leaves all seven patents fully enforceable
Because the dismissal was by stipulation with no merits adjudication, none of Ethicon’s seven asserted patents were held invalid or unenforceable. Any competitor in the articulating robotic surgical instrument space must treat these patents as live enforcement risks until they expire or are challenged via IPR or other post-grant proceedings.
Mutual cost-bearing strongly suggests a negotiated commercial resolution
When parties in high-stakes, multi-patent litigation stipulate to dismissal with prejudice and each bears its own costs after nearly seven years, the public record is typically the tip of an iceberg. A cross-license, royalty arrangement, or strategic commercial agreement is consistent with these terms, though no such agreement is confirmed by the public docket.
Ethicon v Intuitive — key questions answered
All claims were dismissed with prejudice by joint stipulation under Fed. R. Civ. P. 41(a)(1)(A)(ii), filed June 5, 2024. Each party bears its own attorneys’ fees and costs. No merits adjudication was issued, and no damages figure is reflected in the public record. The with-prejudice designation permanently bars Ethicon from refiling the same claims against Intuitive Surgical.
Ethicon asserted seven U.S. patents: US9113874B2, US9084601B2, US8991677B2, US8998058B2, US8479969B2, US8616431B2, and US9585658B2. These patents cover robotic and endoscopic surgical instrument technologies including articulating end-effectors, stapling mechanisms, and instrument drive systems, asserted against the Da Vinci Surgical System and EndoWrist Instruments.
A with-prejudice dismissal constitutes a final judgment on the merits as a matter of law, even absent a court ruling on the substance of the claims. Ethicon is permanently precluded from reasserting these specific infringement claims against Intuitive Surgical. The patents themselves, however, remain in force and could potentially be asserted against other defendants.
The case was filed June 30, 2017 and closed June 5, 2024 — a duration of 2,532 days, or approximately six years and eleven months. This is well above the median duration for patent cases in the District of Delaware, suggesting significant procedural activity including likely claim construction proceedings and potentially parallel USPTO post-grant challenges.
Yes. Because the case was dismissed by stipulation with no invalidity or unenforceability ruling, all seven asserted patents remain legally enforceable until their statutory expiry dates. Companies developing competing robotic surgical instruments should conduct freedom-to-operate analysis against this patent family, particularly given the absence of any limiting claim construction on the public record.
PatSnap Eureka searches patents and litigation data to answer instantly.